Share Analysis of Global Biosimilar Market 2015 Edition

Scope of the Report
The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report.

Purchase a copy of Global Biosimilar Market visit @ http://www.orbisresearch.com/contact/purchase/185270  For more information contact sales@orbisresearch.com   .

Product Coverage
Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
Humira, Enbrel, Remicade, Herceptin
Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)

Company Coverage
Sandoz(Novartis)
Hospira
Teva
Dr. Reddy’s Lab

Executive Summary
Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/185270 .

The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. Globally there are 280 biosimilars in pipeline and their clinical trials are increasing at a rate of 20% annually.

The report titled “The Global Biosimilar Market: Trends & Opportunities (2014-2018)” provides an in-depth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall Biosimilars industry has also been forecasted for the period 2014-18, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled.

Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-biosimilar-market-trends-and-opportunities-2015-edition  .

Some points from TOC:

  1. Executive Summary
  2. Global Biosimilar Market
    2.1 Overview of Biosimilar Market
    2.1.1 History
    2.1.2 Prescription of Biosimilars
    2.1.3 Naming of Biosimilars
    2.1.4 Determination of Biosimilarity
    2.1.5 Differences between Biosimilar and Original Drugs
    2.1.6 Manufacture of Biosimilars
    2.1.7 Safety, Efficacy, Quality
    2.1.8 Variability in Biosimilars
    2.1.9Regulating Biosimilars
    2.1.10 Approval Pathways of Biosimilars
    2.1.11Market Segmentation by Therapeutic Area
  3. Global Biosimilar Market: Sizing and Growth
    3.1 Biosimilar Market Size: 2009-2013
    3.2 Forecasted Biosimilar market Size : 2014-2018

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

Author: Press Release

Publish your press release instantly without any paywall.

Share This Post On

Leave a Reply